Diagnosis of autism and treatment therefor
DCFirst Claim
1. A method of detecting autism-related compounds in a patient comprising the steps of:
- obtaining from the patient a sample of a body fluid selected from the group consisting of urine, blood, saliva and cerebral spinal fluid;
analyzing said sample to determine the quantity therein of at least one compound selected from the group consisting of citramalic acid, 5-hydroxy-methyl-2-furoic acid, 3-oxo-glutaric acid, furan-2,5-dicarboxylic acid, tartaric acid, furancarbonylglycine, arabinose, dihydroxyphenylpropionic acid, carboxycitric acid and phenylcarboxylic acid; and
correlating the quantity of said at least one compound with an autism condition or lack thereof in said patient.
3 Assignments
Litigations
0 Petitions
Accused Products
Abstract
A method for diagnosing the likelihood of autism in patients is provided which comprises first obtaining from the patient a sample of body fluid such as urine and analyzing the sample to determine the quantity therein of at least one marker compound selected from the group consisting of citramalic acid, 5-hydroxy-methyl-2-furoic acid, 3-oxo-glutaric acid, furan-2,5-dicarboxylic acid, tartaric acid, furancarbonylglycine, arabinose, dihydroxyphenylpropionic acid, carboxycitric acid and phenylcarboxylic acid; if the quantities of one or more of the compounds are abnormally high, as compared with the urine of non-autistic individuals, an ultimate diagnosis of autism is likely. The invention also pertains to a method of treating autistic patients by administration of antifungal drugs, in order to ameliorate the clinical symptoms of autism.
94 Citations
7 Claims
-
1. A method of detecting autism-related compounds in a patient comprising the steps of:
-
obtaining from the patient a sample of a body fluid selected from the group consisting of urine, blood, saliva and cerebral spinal fluid; analyzing said sample to determine the quantity therein of at least one compound selected from the group consisting of citramalic acid, 5-hydroxy-methyl-2-furoic acid, 3-oxo-glutaric acid, furan-2,5-dicarboxylic acid, tartaric acid, furancarbonylglycine, arabinose, dihydroxyphenylpropionic acid, carboxycitric acid and phenylcarboxylic acid; and correlating the quantity of said at least one compound with an autism condition or lack thereof in said patient. - View Dependent Claims (2, 3, 4, 5, 6, 7)
-
Specification